Suppr超能文献

BCL6 在 B 细胞中作用的混合机制由增强子和启动子处形成功能不同的复合物来定义。

A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters.

机构信息

Division of Hematology and Medical Oncology, Weill Cornell Medical College, Cornell University, New York, NY 10065, USA.

出版信息

Cell Rep. 2013 Aug 15;4(3):578-88. doi: 10.1016/j.celrep.2013.06.016. Epub 2013 Aug 1.

Abstract

The BCL6 transcriptional repressor is required for the development of germinal center (GC) B cells and diffuse large B cell lymphomas (DLBCLs). Although BCL6 can recruit multiple corepressors, its transcriptional repression mechanism of action in normal and malignant B cells is unknown. We find that in B cells, BCL6 mostly functions through two independent mechanisms that are collectively essential to GC formation and DLBCL, both mediated through its N-terminal BTB domain. These are (1) the formation of a unique ternary BCOR-SMRT complex at promoters, with each corepressor binding to symmetrical sites on BCL6 homodimers linked to specific epigenetic chromatin features, and (2) the "toggling" of active enhancers to a poised but not erased conformation through SMRT-dependent H3K27 deacetylation, which is mediated by HDAC3 and opposed by p300 histone acetyltransferase. Dynamic toggling of enhancers provides a basis for B cells to undergo rapid transcriptional and phenotypic changes in response to signaling or environmental cues.

摘要

BCL6 转录抑制因子是生发中心 (GC) B 细胞和弥漫性大 B 细胞淋巴瘤 (DLBCL) 发育所必需的。尽管 BCL6 可以募集多个核心抑制剂,但它在正常和恶性 B 细胞中的转录抑制作用机制尚不清楚。我们发现,在 B 细胞中,BCL6 主要通过两种独立的机制发挥作用,这两种机制共同对 GC 的形成和 DLBCL 至关重要,均通过其 N 端 BTB 结构域介导。这些机制是:(1)在启动子处形成独特的 BCOR-SMRT 三元复合物,每个核心抑制剂都与连接到特定表观遗传染色质特征的 BCL6 同源二聚体上的对称位点结合;(2)通过 SMRT 依赖性 H3K27 去乙酰化作用,将活性增强子“切换”到一种静止但未被擦除的构象,该过程由 HDAC3 介导,并被 p300 组蛋白乙酰转移酶所拮抗。增强子的动态切换为 B 细胞提供了基础,使其能够在受到信号或环境线索的刺激时迅速发生转录和表型变化。

相似文献

2
BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
Blood. 2007 Sep 15;110(6):2067-74. doi: 10.1182/blood-2007-01-069575. Epub 2007 Jun 1.
4
BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.
Blood. 2009 Dec 17;114(26):5315-21. doi: 10.1182/blood-2009-02-204362. Epub 2009 Oct 23.
5
The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL.
Blood. 2009 May 28;113(22):5536-48. doi: 10.1182/blood-2008-12-193037. Epub 2009 Mar 23.
6
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma.
Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11294-9. doi: 10.1073/pnas.0903854106. Epub 2009 Jun 23.
7
CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas.
Cancer Discov. 2017 Jan;7(1):38-53. doi: 10.1158/2159-8290.CD-16-0975. Epub 2016 Oct 12.
8
BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells.
Blood Cells Mol Dis. 2008 Jul-Aug;41(1):95-9. doi: 10.1016/j.bcmd.2008.02.003. Epub 2008 Mar 17.
9
Mechanisms of action of BCL6 during germinal center B cell development.
Sci China Life Sci. 2015 Dec;58(12):1226-32. doi: 10.1007/s11427-015-4919-z. Epub 2015 Nov 14.
10
BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy.
J Clin Invest. 2010 Dec 1;120(12):4569-82. doi: 10.1172/JCI42869. Epub 2010 Nov 1.

引用本文的文献

2
Epigenetic Regulation of B Cell Memory Formation: A Poised Model for B Cell Epigenetic Reprograming.
J Immunol Res. 2025 Jul 17;2025:9328523. doi: 10.1155/jimr/9328523. eCollection 2025.
3
Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphoma.
PLoS Biol. 2025 Jun 12;23(6):e3003191. doi: 10.1371/journal.pbio.3003191. eCollection 2025 Jun.
4
The TET-TDG axis in T cells and biological processes.
Int Immunol. 2025 May 21;37(6):299-312. doi: 10.1093/intimm/dxaf006.
5
Relocalizing transcriptional kinases to activate apoptosis.
Science. 2024 Oct 4;386(6717):eadl5361. doi: 10.1126/science.adl5361.
6
H3K27ac acts as a molecular switch for doxorubicin-induced activation of cardiotoxic genes.
Clin Epigenetics. 2024 Jul 16;16(1):91. doi: 10.1186/s13148-024-01709-8.
7
Identification and validation of aging-related genes in heart failure based on multiple machine learning algorithms.
Front Immunol. 2024 Apr 15;15:1367235. doi: 10.3389/fimmu.2024.1367235. eCollection 2024.
9
Transcriptional programming of translation by BCL6 controls skeletal muscle proteostasis.
Nat Metab. 2024 Feb;6(2):304-322. doi: 10.1038/s42255-024-00983-3. Epub 2024 Feb 9.
10
CD62L expression marks a functionally distinct subset of memory B cells.
Cell Rep. 2023 Dec 26;42(12):113542. doi: 10.1016/j.celrep.2023.113542. Epub 2023 Dec 5.

本文引用的文献

2
Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo.
Nat Struct Mol Biol. 2013 Feb;20(2):182-7. doi: 10.1038/nsmb.2476. Epub 2013 Jan 6.
4
The Bcl6-SMRT/NCoR cistrome represses inflammation to attenuate atherosclerosis.
Cell Metab. 2012 Apr 4;15(4):554-62. doi: 10.1016/j.cmet.2012.02.012. Epub 2012 Mar 29.
5
PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes.
Mol Cell. 2012 Feb 10;45(3):344-56. doi: 10.1016/j.molcel.2012.01.002.
6
Enhancer decommissioning by LSD1 during embryonic stem cell differentiation.
Nature. 2012 Feb 1;482(7384):221-5. doi: 10.1038/nature10805.
7
An integrated ChIP-seq analysis platform with customizable workflows.
BMC Bioinformatics. 2011 Jul 7;12:277. doi: 10.1186/1471-2105-12-277.
8
Mapping and analysis of chromatin state dynamics in nine human cell types.
Nature. 2011 May 5;473(7345):43-9. doi: 10.1038/nature09906. Epub 2011 Mar 23.
9
Inactivating mutations of acetyltransferase genes in B-cell lymphoma.
Nature. 2011 Mar 10;471(7337):189-95. doi: 10.1038/nature09730.
10
A unique chromatin signature uncovers early developmental enhancers in humans.
Nature. 2011 Feb 10;470(7333):279-83. doi: 10.1038/nature09692. Epub 2010 Dec 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验